FDA Drug Warning Missed By Many

A FDA warning about high doses of the cholesterol-lowering drug Simvastatin was not aggressively advertised to patients or physicians after they were pushed to switch from statins like Lipitor to the less-expensive drug by pharmacy-benefit plans, according to physicians familiar with the drug.

Leave a Reply

Your email address will not be published.

*